Autopsy report · NCT01597570
Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System
Cause of deathNo reason given
Life of this trial
- Ran for about 7 months before it stopped.
- 52 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Taewoong Medical Co., Ltd.
- Sponsor type
- Industry
- Conditions
- The Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter Removal
- Interventions
- Vascular Closure Device
- Participants
- 52
- Sites
- 2
- Countries
- South Korea
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.